Literature DB >> 23567316

Neonatal exposure to lipopolysaccharide enhances accumulation of α-synuclein aggregation and dopamine transporter protein expression in the substantia nigra in responses to rotenone challenge in later life.

Lu-Tai Tien1, Asuka Kaizaki, Yi Pang, Zhengwei Cai, Abhay J Bhatt, Lir-Wan Fan.   

Abstract

Brain inflammation in early life may enhance adult susceptibility to develop neurodegenerative disorders triggered by environmental toxins. Our previous studies show that perinatal lipopolysaccharide (LPS) exposure enhances adult susceptibility to rotenone-induced injury to the dopaminergic system in the substantia nigra (SN) of the adult rat brain. To further investigate the enhanced adult susceptibility by neonatal LPS exposure to rotenone neurotoxicity, we used our neonatal rat model of LPS exposure (1mg/kg, intracerebral injection in postnatal day 5, P5, neonatal rats) to examine the protein levels of α-synuclein and dopamine transporters (DAT) in the adult rat. By P70, rats from the saline- or LPS-exposed group were challenged with rotenone, a commonly used pesticide, through subcutaneous mini-pump infusion at a dose of 1.25mg/kg/day for 14 days. The accumulation of α-synuclein aggregation and increment of DAT protein content were found in the SN of LPS-exposed rats. Neonatal LPS exposure enhanced rotenone-stimulated accumulation of α-synuclein aggregation and increment in DAT protein expression in the cytoplasmic compartment of the SN, and in the synaptosomal compartment of the striatum of adult rats. Rotenone treatment also resulted in reduction of [(3)H]dopamine uptake and mitochondrial complex I activity in the striatum of rats with neonatal LPS exposure, but not in those without this exposure. The current study suggests possible roles of α-synuclein aggregate and DAT distribution in the cytoplasm and synaptosome triggered by environmental toxins in later life in the development of neurodegenerative disorders. Our model may be useful in studying mechanisms involved in the pathogenesis of nonfamilial Parkinson's disease and for developing potential therapeutic treatments for this disease.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23567316      PMCID: PMC3676711          DOI: 10.1016/j.tox.2013.03.014

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  53 in total

1.  CSF levels of oligomeric alpha-synuclein and beta-amyloid as biomarkers for neurodegenerative disease.

Authors:  Michael R Sierks; Gaurav Chatterjee; Claire McGraw; Srinath Kasturirangan; Philip Schulz; Shalini Prasad
Journal:  Integr Biol (Camb)       Date:  2011-11-10       Impact factor: 2.192

2.  Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone.

Authors:  Sheila M Fleming; Chunni Zhu; Pierre-Olivier Fernagut; Arpesh Mehta; Cheryl D DiCarlo; Ronald L Seaman; Marie-Françoise Chesselet
Journal:  Exp Neurol       Date:  2004-06       Impact factor: 5.330

3.  Neocortical localization of tactile/proprioceptive limb placing reactions in the rat.

Authors:  M De Ryck; J Van Reempts; H Duytschaever; B Van Deuren; G Clincke
Journal:  Brain Res       Date:  1992-02-21       Impact factor: 3.252

4.  Neonatal exposure to lipopolysaccharide enhances vulnerability of nigrostriatal dopaminergic neurons to rotenone neurotoxicity in later life.

Authors:  Lir-Wan Fan; Lu-Tai Tien; Rick C S Lin; Kimberly L Simpson; Philip G Rhodes; Zhengwei Cai
Journal:  Neurobiol Dis       Date:  2011-07-28       Impact factor: 5.996

5.  In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain.

Authors:  ZaoDung Ling; Dave A Gayle; Shang Yong Ma; Jack W Lipton; Chong Wai Tong; Jau-Shyong Hong; Paul M Carvey
Journal:  Mov Disord       Date:  2002-01       Impact factor: 10.338

6.  Testing forelimb placing "across the midline" reveals distinct, lesion-dependent patterns of recovery in rats.

Authors:  Martin T Woodlee; Aloysha M Asseo-García; Xiurong Zhao; Shi-Jie Liu; Theresa A Jones; Timothy Schallert
Journal:  Exp Neurol       Date:  2005-02       Impact factor: 5.330

7.  Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma.

Authors:  Omar M A El-Agnaf; Sultan A Salem; Katerina E Paleologou; Leanne J Cooper; Nigel J Fullwood; Mark J Gibson; Martin D Curran; Jennifer A Court; David M A Mann; Shu-ichi Ikeda; Mark R Cookson; John Hardy; David Allsop
Journal:  FASEB J       Date:  2003-08-15       Impact factor: 5.191

8.  Mechanisms underlying methamphetamine-induced dopamine transporter complex formation.

Authors:  Gregory C Hadlock; Anthony J Baucum; Jill L King; Kristen A Horner; Glen A Cook; James W Gibb; Diana G Wilkins; Glen R Hanson; Annette E Fleckenstein
Journal:  J Pharmacol Exp Ther       Date:  2009-01-13       Impact factor: 4.030

9.  Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats.

Authors:  Chun-Hung Lin; Jui-Yen Huang; Cheng-Hsin Ching; Jih-Ing Chuang
Journal:  J Pineal Res       Date:  2008-03       Impact factor: 13.007

10.  Cyclooxygenase and neuroinflammation in Parkinson's disease neurodegeneration.

Authors:  Anna L Bartels; Klaus L Leenders
Journal:  Curr Neuropharmacol       Date:  2010-03       Impact factor: 7.363

View more
  8 in total

1.  Consequences of developmental exposure to concentrated ambient ultrafine particle air pollution combined with the adult paraquat and maneb model of the Parkinson's disease phenotype in male mice.

Authors:  Joshua L Allen; Xiufang Liu; Douglas Weston; Katherine Conrad; Günter Oberdörster; Deborah A Cory-Slechta
Journal:  Neurotoxicology       Date:  2014-01-30       Impact factor: 4.294

2.  Lipoic acid protects dopaminergic neurons in LPS-induced Parkinson's disease model.

Authors:  Yan-Hua Li; Qing He; Jie-zhong Yu; Chun-yun Liu; Ling Feng; Zhi Chai; Qing Wang; Hong-zhen Zhang; Guang-Xian Zhang; Bao-guo Xiao; Cun-gen Ma
Journal:  Metab Brain Dis       Date:  2015-06-19       Impact factor: 3.584

3.  Alteration of the brain methylation landscape following postnatal inflammatory injury in rat pups.

Authors:  Wyston C Pierre; Lisa-Marie Legault; Irene Londono; Serge McGraw; Gregory A Lodygensky
Journal:  FASEB J       Date:  2019-11-22       Impact factor: 5.191

4.  Achyranthes bidentata polypeptide alleviates neurotoxicity of lipopolysaccharide-activated microglia via PI3K/Akt dependent NOX2/ROS pathway.

Authors:  Yitong Wang; Xiangyu Ge; Shu Yu; Qiong Cheng
Journal:  Ann Transl Med       Date:  2021-10

Review 5.  Gut microbiota dysbiosis: The potential mechanisms by which alcohol disrupts gut and brain functions.

Authors:  Ganggang Chen; Fenglei Shi; Wei Yin; Yao Guo; Anru Liu; Jiacheng Shuai; Jinhao Sun
Journal:  Front Microbiol       Date:  2022-07-29       Impact factor: 6.064

Review 6.  Models of α-synuclein aggregation in Parkinson's disease.

Authors:  Rosa Giráldez-Pérez; Mónica Antolín-Vallespín; María Muñoz; Amelia Sánchez-Capelo
Journal:  Acta Neuropathol Commun       Date:  2014-12-13       Impact factor: 7.801

Review 7.  Neuroinflammation in Multiple System Atrophy: Response to and Cause of α-Synuclein Aggregation.

Authors:  Bruno Di Marco Vieira; Rowan A Radford; Roger S Chung; Gilles J Guillemin; Dean L Pountney
Journal:  Front Cell Neurosci       Date:  2015-11-12       Impact factor: 5.505

Review 8.  Brain Kynurenine and BH4 Pathways: Relevance to the Pathophysiology and Treatment of Inflammation-Driven Depressive Symptoms.

Authors:  Sylvie Vancassel; Lucile Capuron; Nathalie Castanon
Journal:  Front Neurosci       Date:  2018-07-24       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.